Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yoko S. DeRose"'
Autor:
Sandra D. Scherer, Alessandra I. Riggio, Fadi Haroun, Yoko S. DeRose, H. Atakan Ekiz, Maihi Fujita, Jennifer Toner, Ling Zhao, Zheqi Li, Steffi Oesterreich, Ahmed A. Samatar, Alana L. Welm
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-18 (2021)
Abstract Background Metastatic breast cancer (MBC) is incurable, with a 5-year survival rate of 28%. In the USA, more than 42,000 patients die from MBC every year. The most common type of breast cancer is estrogen receptor-positive (ER+), and more pa
Externí odkaz:
https://doaj.org/article/9f5a018b7d5f4111b5c00b06970d1c1d
Autor:
Jason J. Zoeller, Aleksandr Vagodny, Veerle W. Daniels, Krishan Taneja, Benjamin Y. Tan, Yoko S. DeRose, Maihi Fujita, Alana L. Welm, Anthony Letai, Joel D. Leverson, Vincent Blot, Roderick T. Bronson, Deborah A. Dillon, Joan S. Brugge
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-13 (2020)
Abstract Background Targeted therapies for triple-negative breast cancer (TNBC) are limited; however, the epidermal growth factor receptor (EGFR) represents a potential target, as the majority of TNBC express EGFR. The purpose of these studies was to
Externí odkaz:
https://doaj.org/article/7961025b271046ca91a4d856080ab647
Autor:
Siwen Hu-Lieskovan, Ngan Nguyen, Magdalena Kovacsovics-Bankowski, John Hyngstrom, Li-Chun Cheng, Jordan P McPherson, Umang Swami, Matthew H Spitzer, Johanna M Sweere, Connor P Healy, Natalia Sigal, William D Chronister, Shane A Evans, John Marsiglio, Berit Gibson, Alyssa Erickson-Wayman, Yoko S Derose, Annaleah Larson Eliason, Carlos O Medina, Ramji Srinivasan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Immune-related adverse events (irAEs) are major barriers of clinical management and further development of immune checkpoint inhibitors (ICIs) for cancer therapy. Therefore, biomarkers associated with the onset of severe irAEs are needed.
Externí odkaz:
https://doaj.org/article/33adf4f87d5845b590a6128eac8e0678
Autor:
Karen Cichowski, Charlotte Kuperwasser, Sandra S. McAllister, Ann H. Partridge, Alana Welm, Massimo Loda, Stephanie Guerra, Wenhui Zhou, Yoko S. DeRose, Miriam Enos, Thomas De Raedt, Clare Malone, Benjamin Dake, Zafira Castaño, Ania Wronski, Sarah Naomi Olsen
Ras Pathway Activation upon Rescue with wild-type or GAP-mutant DAB2IP and RASAL2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a54a28adda149675c3df7b91ef2cf2
https://doi.org/10.1158/2159-8290.22531870
https://doi.org/10.1158/2159-8290.22531870
Autor:
Karen Cichowski, Charlotte Kuperwasser, Sandra S. McAllister, Ann H. Partridge, Alana Welm, Massimo Loda, Stephanie Guerra, Wenhui Zhou, Yoko S. DeRose, Miriam Enos, Thomas De Raedt, Clare Malone, Benjamin Dake, Zafira Castaño, Ania Wronski, Sarah Naomi Olsen
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0306a17ef62ece3adb10c32821cbf453
https://doi.org/10.1158/2159-8290.22531882.v1
https://doi.org/10.1158/2159-8290.22531882.v1
Autor:
Karen Cichowski, Charlotte Kuperwasser, Sandra S. McAllister, Ann H. Partridge, Alana Welm, Massimo Loda, Stephanie Guerra, Wenhui Zhou, Yoko S. DeRose, Miriam Enos, Thomas De Raedt, Clare Malone, Benjamin Dake, Zafira Castaño, Ania Wronski, Sarah Naomi Olsen
Various Annotations of ER+ Breast Cancer Cell Lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bac7329ce518133d5c8a34c35821940
https://doi.org/10.1158/2159-8290.22531867.v1
https://doi.org/10.1158/2159-8290.22531867.v1
Autor:
Katrin P. Guillen, Maihi Fujita, Andrew J. Butterfield, Sandra D. Scherer, Matthew H. Bailey, Zhengtao Chu, Yoko S. DeRose, Ling Zhao, Emilio Cortes-Sanchez, Chieh-Hsiang Yang, Jennifer Toner, Guoying Wang, Yi Qiao, Xiaomeng Huang, Jeffery A. Greenland, Jeffery M. Vahrenkamp, David H. Lum, Rachel E. Factor, Edward W. Nelson, Cindy B. Matsen, Jane M. Poretta, Regina Rosenthal, Anna C. Beck, Saundra S. Buys, Christos Vaklavas, John H. Ward, Randy L. Jensen, Kevin B. Jones, Zheqi Li, Steffi Oesterreich, Lacey E. Dobrolecki, Satya S. Pathi, Xing Yi Woo, Kristofer C. Berrett, Mark E. Wadsworth, Jeffrey H. Chuang, Michael T. Lewis, Gabor T. Marth, Jason Gertz, Katherine E. Varley, Bryan E. Welm, Alana L. Welm
Publikováno v:
Nature Cancer. 3:232-250
Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenografts (PDXs) and matched organoid cultures from tumors that represent the greatest
Autor:
Maihi Fujita, Alana L. Welm, Zheqi Li, Steffi Oesterreich, Yoko S. DeRose, Jennifer Toner, Alessandra I. Riggio, Ahmed A. Samatar, Fadi Haroun, Ling Zhao, H. Atakan Ekiz, Sandra D. Scherer
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 23, Iss 1, Pp 1-18 (2021)
Breast Cancer Research, Vol 23, Iss 1, Pp 1-18 (2021)
Background Metastatic breast cancer (MBC) is incurable, with a 5-year survival rate of 28%. In the USA, more than 42,000 patients die from MBC every year. The most common type of breast cancer is estrogen receptor-positive (ER+), and more patients di
Autor:
Ward Jh, Randy L. Jensen, Ling Zhao, Greenland Ja, Maihi Fujita, Rosenthal R, Saundra S. Buys, Anna C. Beck, Guoying Wang, Wadsworth Me, Emilio Cortes-Sanchez, Sandra D. Scherer, Chieh-Hsiang Yang, Katrin P. Guillen, Jeffrey H. Chuang, Cindy B. Matsen, Zheqi Li, Kristopher Berrett, Jeffery M. Vahrenkamp, David H. Lum, Alana L. Welm, Michael T. Lewis, Toner J, Jason Gertz, Chu Z, Poretta Jm, Yoko S. DeRose, Lacey E. Dobrolecki, Gabor T. Marth, Katherine E. Varley, Rachel E. Factor, Andrew Butterfield, Bryan E. Welm, Xiaomeng Huang, Edward W. Nelson, Matthew H. Bailey, Pathi Ss, Xing Yi Woo, Yi Qiao, Christos Vaklavas, Steffi Oesterreich, Kevin B. Jones
Model systems that recapitulate the complexity of human tumors and the reality of variable treatment responses are urgently needed to better understand cancer biology and to develop more effective cancer therapies. Here we report development and char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb9f2dc64567b20d35abfdfca6812bd3
https://doi.org/10.1101/2021.02.28.433268
https://doi.org/10.1101/2021.02.28.433268
Autor:
Yoko S. DeRose, Jessica L. Kohan, Isaac E. Lloyd, Rachel E. Factor, Mohamed E. Salama, Leigh Neumayer, Elisabeth Malmberg, Alana L. Welm
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 26(7)
Context College of American Pathologists (CAP) and the American Society of Clinical Oncology have emphasized the need to reduce preanalytic variables for evaluating predictive biomarker expression in breast cancer. Postoperative x-ray of excised brea